Keysight Technologies, Inc. (NYSE: KEYS) introduced a new portfolio of scale-up validation solutions designed to help ...

Jonathan Andrus, co-CEO of CRIO, explains how protocol-driven eSource templates and standardized data capture are improving consistency, oversight, and efficiency across clinical trial sites.

Can Zero-Knowledge Proofs reduce validation risk in cross-chain transfers? Know how ZKPs replace trusted validators with cryptographic proofs to secure bridges.

Regulators are modernizing their expectations, and it's become clear that validation can no longer function as a point-in-time event.